Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.
J Neuroimmune Pharmacol
; 16(3): 519-530, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1283811
ABSTRACT
This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia Symposium 1 Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2 Therapeutic and vaccine approaches to COVID-19; Symposium 3 Early Career Investigator talks; and Symposium 4 Diversity and Inclusion SNIP Committee (DISC) program Well-being and reflections. The workshop also featured four special talks on COVID-19 and funding opportunities from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); COVID-19 and funding opportunities from the National Institute on Drug Abuse (NIDA); opportunities from NIH for early career investigator (ECI) fellows; and neurologic and psychiatric complications of SARS-CoV-2 infection. Presenters included NIH officials, SNIP members, and non-member scientists whose abstracts were submitted and accepted for inclusion in the virtual event hosted by the University of Nebraska Medical Center via Zoom webinar. A special theme issue of SNIP's official journal, the Journal of Neuroimmune Pharmacology (JNIP), will collect select papers from the workshop along with other related manuscripts in a special theme issue titled "Neuroimmune Pharmacology of SARS-CoV-2."
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Societies, Scientific
/
Neuroimmunomodulation
/
Education
/
COVID-19
/
COVID-19 Drug Treatment
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Neuroimmune Pharmacol
Journal subject:
Allergy and Immunology
/
Pharmacology
/
Neurology
Year:
2021
Document Type:
Article
Affiliation country:
S11481-021-10001-y
Similar
MEDLINE
...
LILACS
LIS